Post-approval studies (Phase 4)Study completedNCT01806298
What this trial is testing
An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 78